Log In
BCIQ
Print this Print this
 

FM101

  Manage Alerts
Collapse Summary General Information
Company Femta Pharmaceuticals Inc.
DescriptionRecombinant humanized mAb targeting IL-6
Molecular Target Interleukin-6 (IL-6)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA) in patients refractory to methotrexate
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today